Company intelligence / Profile preview

Kai

Jeonju-si, Jeollabuk-do, South Korea

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Kai Biotech is a South Korea-based radiopharmaceutical company focused on diagnostic and therapeutic products built on radioactive fusion technology. The company develops and markets radiopharmaceuticals for oncology and brain disease applications, with disclosed product activity in pheochromocytoma, neuroblastoma, liver cancer, and dementia diagnostics. Public company sources describe Kai Biotech as manufacturing and selling radiopharmaceutical products, suggesting it has moved beyond a pure development-stage model. The company appears to be relatively small and headquartered in Jeonju, South Korea.

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: RadiopharmaceuticalSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Kai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kai.

Explore the full profile